Vitamin K Deficiency: Newborn Bleeding (VKDB)

Every baby is born with very little vitamin K, and breast milk — for all its other gifts — carries almost none. That leaves a newborn briefly unable to make some of the proteins the blood needs to clot, and a small number of these babies bleed: into the gut, from the umbilical stump, and most devastatingly into the brain. The condition is called vitamin K deficiency bleeding (VKDB), and it is one of the very few catastrophes of infancy that a single, painless injection at birth essentially erases. This page explains why newborns are uniquely vulnerable, what the bleeding looks like, why the “K shot” works so well, and what the research shows about the risk of declining it.


Table of Contents

  1. What VKDB Looks Like in a Baby
  2. The Mechanism: Why a Newborn Can't Clot Well
  3. Early, Classic, and Late VKDB
  4. Honesty: Bleeding in Babies Has Other Causes Too
  5. Clues That Point to Vitamin K
  6. Who Is at Highest Risk
  7. The Vitamin K Shot: What It Is and Why It Works
  8. Oral Drops, and the Risk of Declining
  9. How VKDB Is Diagnosed
  10. Treating Active Bleeding
  11. When to Seek Care / Red Flags
  12. Key Research Papers
  13. Connections
  14. Featured Videos

What VKDB Looks Like in a Baby

A baby cannot tell you that something is wrong, so VKDB announces itself through bleeding that a parent or clinician sees. The presentations range from frightening-but-treatable to silently catastrophic, and what makes the condition so dangerous is that the most serious form — bleeding into the brain — can be the first and only sign, with no warning bruise beforehand.

The bleeding can show up in several ways:

The cruel arithmetic of VKDB is in those last bullets. Roughly half of babies who develop the late form bleed into the brain, and of those, a large fraction die or are left with permanent neurological injury — from a deficiency that costs almost nothing to prevent.

Back to Table of Contents

The Mechanism: Why a Newborn Can't Clot Well

To understand VKDB you have to understand one specific job that vitamin K does. Several of the proteins that make blood clot — the clotting factors II (prothrombin), VII, IX, and X, plus the regulatory proteins C and S — are manufactured in the liver in an inactive form. Before they can grip calcium and lock onto the surface of a forming clot, an enzyme has to add a chemical “hook” (a second carboxyl group) to specific glutamate building blocks in each protein. That reaction, called gamma-carboxylation, only works if vitamin K is present to power it. Vitamin K is the cofactor; without it, the liver still makes the clotting factors, but they come off the assembly line non-functional — present in the blood yet unable to do their job. (See Vitamin K and Blood Clotting for the full cascade.)

An analogy. Think of vitamin K as the key that activates a set of brand-new fire extinguishers (the clotting factors). The factory ships the extinguishers fully built, but with the safety pin glued in. Vitamin K is the only tool that pulls the pin. With no vitamin K, the shelves are stocked with extinguishers that look ready but cannot spray a drop — so when a fire (a bleed) starts, nothing puts it out.

Newborns are uniquely short of this key for several reasons that stack on top of each other:

The result is a narrow but real window — from birth through the first several months — in which a baby's clotting system runs on a nearly empty tank. Formula-fed infants are partly protected because infant formula is fortified with vitamin K; exclusively breastfed infants who did not receive vitamin K at birth are the classic at-risk group.

Back to Table of Contents

Early, Classic, and Late VKDB

VKDB is traditionally divided into three forms by when the bleeding happens, because the timing tells you a lot about the cause and the risk.

The late form is the heart of the modern story. Early and classic VKDB became rare once hospitals began giving vitamin K at birth; late VKDB is the form that re-emerges, sometimes in clusters, in communities where families decline the injection.

Back to Table of Contents

Honesty: Bleeding in Babies Has Other Causes Too

It would be misleading to suggest that any bleeding or bruising in a newborn means vitamin K deficiency. It does not. A baby who bleeds easily needs a careful evaluation, because several other conditions produce a very similar picture, and a few of them are emergencies in their own right:

The practical point for parents is reassuring and important at once: bleeding in a baby is taken seriously and worked up properly, so a baby who bleeds is not simply assumed to be vitamin K deficient — but neither is vitamin K deficiency ever dismissed, because it is both common in unsupplemented infants and almost completely preventable.

Back to Table of Contents

Clues That Point to Vitamin K

Certain features make vitamin K deficiency the leading suspect among the causes above, and they are the clues a clinician weighs quickly:

For the broader, all-ages picture of how low vitamin K shows up as bleeding and bruising, see the sibling page Bleeding and Easy Bruising; this page focuses specifically on the newborn.

Back to Table of Contents

Who Is at Highest Risk

VKDB does not strike at random. The babies who develop it fall into a few clear groups, and recognizing them is the whole basis of prevention:

The first two groups overlap heavily, and together they describe the typical late-VKDB baby: healthy-appearing, exclusively breastfed, sent home without the injection, who suddenly deteriorates at a few weeks of age.

How large the risk is. A 2016 systematic review (Sankar) found that late VKDB occurred in a median of 35 per 100,000 live births in infants who had not received prophylaxis at birth — 80 per 100,000 in low- and middle-income countries against 8.8 per 100,000 in high-income countries. In four surveillance studies, vitamin K given by injection (into the muscle or under the skin) cut the risk of late VKDB to a pooled relative risk of 0.02 compared with no prophylaxis.

A concrete example. Doctors in Tennessee reported that over an eight-month period they saw seven infants with confirmed vitamin K deficiency, at a mean age of 10.3 weeks (range 7–20 weeks). None had received vitamin K at birth. Four of the seven had bleeding inside the skull (intracranial hemorrhage), and two of those needed urgent neurosurgery (Schulte 2014).

Back to Table of Contents

The Vitamin K Shot: What It Is and Why It Works

Since the American Academy of Pediatrics first recommended it in 1961, the standard of care in the United States and many other countries has been a single intramuscular injection of vitamin K1 (phytonadione) given to every newborn shortly after birth — usually 0.5 mg for babies under about 1.5 kg and 1 mg for larger babies. It is given into the thigh muscle, takes seconds, and is one of the most cost-effective preventive measures in all of medicine.

Why does a single shot work so well? The intramuscular dose does two things at once. First, it immediately tops up the baby's empty tank, providing enough vitamin K to activate the clotting factors right away — covering the classic, first-week risk. Second, and crucially, the muscle acts as a slow-release depot: the vitamin K is absorbed gradually over the following weeks, bridging the baby through the dangerous late-VKDB window until breastfeeding is established, solids begin, and the gut bacteria start contributing their own supply. One injection, in other words, covers both the early and the late threat.

The effect is very large in surveillance studies, though the evidence for the late form comes from observational data, not randomized trials: the 2016 Sankar systematic review found no randomized trials of prophylaxis against late VKDB, and rated as low quality the observational evidence that 1 mg of intramuscular vitamin K at birth reduces late VKDB. A single intramuscular dose at birth has been shown for decades to prevent classic VKDB and to dramatically reduce the catastrophic late form. The historical “before-and-after” is stark: in populations that adopted universal injection, classic VKDB nearly vanished and late VKDB with brain hemorrhage became rare; in populations that abandoned or declined it, those bleeds returned. Modern reviews and the current American Academy of Pediatrics clinical report reaffirm the intramuscular injection as the standard.

A note on an old fear: in the early 1990s a single study raised a possible link between intramuscular vitamin K and childhood cancer. That alarm drove some countries toward oral dosing. It has since been thoroughly refuted — many large, careful studies found no association between vitamin K and cancer, and the major pediatric bodies regard the question as closed. Unfortunately, the original scare is still occasionally cited online.

Back to Table of Contents

Oral Drops, and the Risk of Declining

Some families ask about oral vitamin K instead of the injection. Oral regimens do exist and are used routinely in some countries, but they come with important caveats that parents deserve to hear plainly:

The far more consequential decision is declining vitamin K altogether. When parents refuse it, the baby is left with the empty-tank physiology described above and no backstop. Multiple countries have documented a measurable resurgence of late VKDB — including clusters of infants with intracranial hemorrhage — directly attributable to rising refusal of the injection. The medical and ethical literature is unusually blunt on this point: declining vitamin K exposes a healthy baby to a small but real chance of a preventable, often-lethal brain bleed, for no countervailing benefit. Refusal rates have been linked to misinformation (the debunked cancer scare, the idea that anything “injected” is unnatural, and confusion with vaccine debates), and correcting that misinformation is one of the highest-value conversations in newborn care.

The Centers for Disease Control and Prevention (CDC) reports that without prophylaxis, late VKDB occurs in 4.4 to 7.2 per 100,000 infants, and that the relative risk of late VKDB has been estimated at 81 times greater among infants who do not receive intramuscular vitamin K than among infants who do. Recent national data put numbers on the trend:

The bottom line, as the major pediatric bodies state it: the American Academy of Pediatrics has recommended intramuscular vitamin K at birth since 1961 and reaffirmed it in its 2022 clinical report, and the 2016 Sankar review concluded that it “seems appropriate to administer IM vitamin K prophylaxis to all neonates at birth.” For families who decline the injection, an oral regimen with strict adherence is the alternative in use; the Swiss three-dose oral regimen above is one example.

Back to Table of Contents

How VKDB Is Diagnosed

When a young infant presents with unexplained bleeding, the workup is fast because the treatable possibilities are time-critical. The cornerstone is a set of coagulation tests — see the Coagulation Panel for the full set:

If the baby has signs of intracranial bleeding, brain imaging (ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI)) is done urgently in parallel, because the bleed itself may need neurosurgical attention while the clotting is being corrected. A Complete Blood Count checks the platelet count and how much blood has been lost, and liver tests look for an underlying hepatic cause.

Back to Table of Contents

Treating Active Bleeding

Once VKDB is suspected, treatment does not wait for every result to come back — the priority is to replace vitamin K and, if bleeding is serious, to replace the missing clotting factors directly:

For the babies who survive an intracranial hemorrhage, the aftermath can include neurosurgery to relieve pressure, intensive care, and a long road of developmental follow-up. This is precisely why the entire field leans so hard on prevention: treatment of established brain bleeding, however skilled, cannot undo the injury that the injection would have prevented.

Back to Table of Contents

When to Seek Care / Red Flags

For any infant — but especially one who did not receive vitamin K at birth — the following are emergencies. Call emergency services or go to the nearest emergency department immediately; do not wait for a routine appointment:

Upstream of all of this sits the vitamin K injection at birth: in the 2026 US study, infants who did not receive it had 2.43 times the adjusted risk of bleeding inside the skull. It is the difference between this entire page being a description of a near-eliminated disease and a description of one that is quietly returning.

Back to Table of Contents

Key Research Papers

  1. Hand I, Noble L, Abrams SA (2022). Vitamin K and the Newborn Infant (AAP Clinical Report). Pediatrics;149(3):e2021056036. — DOI: 10.1542/peds.2021-056036. — doi:10.1542/peds.2021-056036
  2. American Academy of Pediatrics, Committee on Fetus and Newborn (2003). Controversies Concerning Vitamin K and the Newborn. Pediatrics;112(1):191-192. — DOI: 10.1542/peds.112.1.191. — doi:10.1542/peds.112.1.191
  3. Shearer MJ (2009). Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Reviews;23(2):49-59. — DOI: 10.1016/j.blre.2008.06.001. — doi:10.1016/j.blre.2008.06.001
  4. Araki S, Shirahata A (2020). Vitamin K Deficiency Bleeding in Infancy. Nutrients;12(3):780. — DOI: 10.3390/nu12030780. — doi:10.3390/nu12030780
  5. Sankar MJ, Chandrasekaran A, Kumar P, et al. (2016). Vitamin K prophylaxis for prevention of vitamin K deficiency bleeding: a systematic review. Journal of Perinatology;36(Suppl 1):S29-S35. — DOI: 10.1038/jp.2016.30. — doi:10.1038/jp.2016.30
  6. Puckett RM, Offringa M (2000). Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Cochrane Database of Systematic Reviews;(4):CD002776. — DOI: 10.1002/14651858.cd002776. — doi:10.1002/14651858.cd002776
  7. Sutor AH, von Kries R, Cornelissen EA, McNinch AW, Andrew M (1999). Vitamin K deficiency bleeding (VKDB) in infancy. ISTH Pediatric/Perinatal Subcommittee. Thrombosis and Haemostasis;81(3):456-461. — DOI: 10.1055/s-0037-1614494. — doi:10.1055/s-0037-1614494
  8. Barton JS, McNinch AW, Tripp JH (1994). Oral vitamin K prophylaxis and frequency of late vitamin K deficiency bleeding [letter]. The Lancet;343(8906):1168. — DOI: 10.1016/s0140-6736(94)90277-1. — doi:10.1016/s0140-6736(94)90277-1
  9. Schulte R, Jordan LC, Morad A, Naftel RP, Wellons JC 3rd, Sidonio R (2014). Rise in late onset vitamin K deficiency bleeding in young infants because of omission or refusal of prophylaxis at birth. Pediatric Neurology;50(6):564-568. — DOI: 10.1016/j.pediatrneurol.2014.02.013. — PubMed PMID: 24842255
  10. Centers for Disease Control and Prevention (CDC) (2013). Notes from the field: late vitamin K deficiency bleeding in infants whose parents declined vitamin K prophylaxis—Tennessee, 2013. MMWR Morbidity and Mortality Weekly Report;62(45):901-902. — PubMed PMID: 24226627
  11. Block SL (2014). Playing Newborn Intracranial Roulette: Parental Refusal of Vitamin K Injection. Pediatric Annals;43(2):53-59. — DOI: 10.3928/00904481-20131223-04. — doi:10.3928/00904481-20131223-04
  12. Kerruish NJ, McMillan J, Wheeler BJ (2017). The ethics of parental refusal of newborn vitamin K prophylaxis. Journal of Paediatrics and Child Health;53(1):8-11. — DOI: 10.1111/jpc.13364. — doi:10.1111/jpc.13364
  13. Scott K, Handley SC, Lo JY, et al. (2026). Nonreceipt of Newborn Vitamin K and Risk of Bleeding. JAMA;e2621764 (online ahead of print). — DOI: 10.1001/jama.2026.21764. — PubMed PMID: 42986716
  14. Simatou E, Tsamantioti E, Hallström A, Stephansson O, Razaz N, Persson M, Bolk J (2026). Vitamin K Prophylaxis in Newborns and Bleeding in Infancy. JAMA Pediatrics;180(9):995-1004. — DOI: 10.1001/jamapediatrics.2026.2606. — PubMed PMID: 42440325
  15. Laubscher B, Schubiger G, Rizzi M; Swiss Paediatric Surveillance Unit (SPSU) (2026). Oral neonatal vitamin K deficiency bleeding prophylaxis in Switzerland (2018-2024), still valid guidelines for healthy infants. European Journal of Pediatrics;185(2):82. — DOI: 10.1007/s00431-025-06730-4. — PubMed PMID: 41545738

PubMed Topic Searches

  1. PubMed: Vitamin K deficiency bleeding of the newborn
  2. PubMed: Late VKDB and intracranial hemorrhage
  3. PubMed: Intramuscular vs oral vitamin K prophylaxis
  4. PubMed: Parental refusal of newborn vitamin K
  5. PubMed: Vitamin K injection and childhood cancer (refuted)

Back to Table of Contents

Connections

Back to Table of Contents